US Patent Issued to The General Hospital on Nov. 4 for "Dextroamphetamine and lisdexamfetamine to reverse dexmedetomidine sedation" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,609, issued on Nov. 4, was assigned to The General Hospital Corp. (Boston).

"Dextroamphetamine and lisdexamfetamine to reverse dexmedetomidine sedation" was invented by Ken Solt (Lexington, Mass.), Oluwaseun Johnson-Akeju (Lexington, Mass.) and Emery N. Brown (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions, e.g., compositions for intravenous administration, comprising dextroamphetamine and/or lisdexamfetamine for use in reversal of dexmedetomidine sedation."

The patent was filed on Dec. 19, 2019, under Application No. 17/415,229.

*For further information, including images, charts and tables, please visit: h...